This page includes the latest FDA filings for Primus Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Registration Number | 3006052875 |
FEI Number | 3006052875 |
Name | PRIMUS PHARMACEUTICALS, INC. |
Owner & Operator | Primus Pharmaceuticals |
Contact Address | 7373 N. Scottsdale Rd Suite B-200 Scottsdale AZ 85253 US |
Official Correspondent |
|
Registration Status | 1 |
Initial Importer | N |
Registration Expiration | 2020-04-25 |
Registration Address | 7373 N SCOTTSDALE RD STE B200 Scottsdale, AZ 85253 US |
Establishment Type | Develop Specifications But Do Not Manufacture At This Facility |
Device Company | Device | Date |
---|---|---|
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited | Prescription Medication | 2024-01-31 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited, DPT Laboratories, Ltd. | Prescription Medication | 2024-01-31 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited | Prescription Medication | 2023-11-21 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited, DPT Laboratories, Ltd. | Prescription Medication | 2023-11-21 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited | Prescription Medication | 2022-02-26 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited, DPT Laboratories, Ltd. | Prescription Medication | 2021-12-02 |
Primus Pharmaceuticals, Inc. | Impoyz | 2021-12-01 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited | Prescription Medication | 2021-08-05 |
Primus Pharmaceuticals, Inc., Symbiotec Pharmalab Private Limited | Prescription Medication | 2021-07-17 |
Primus Pharmaceuticals, Inc. | Sernivo | 2021-06-28 |
PRIMUS PHARMACEUTICALS, INC. [Primus Pharmaceuticals] | EpiCeram | 2018-04-16 |
Primus Pharmaceuticals, Inc, Medline Industries, Inc | Other Medication | 2014-12-13 |
Primus Pharmaceuticals, Inc., Cornerstone Research & Development, Inc. | Other Medication | 2013-01-17 |
Primus Pharmaceuticals, Inc., Cornerstone Research & Development, Inc | Other Medication | 2012-03-27 |
NCAGE Code | 61UD5 | PRIMUS PHARMACEUTICALS, INC. |
CAGE Code | 61UD5 | PRIMUS PHARMACEUTICALS, INC. |
SEC | 0000819400 | PRIMUS PHARMACEUTICALS INC of GEORGIA |